{"id":"https://openalex.org/W2119257560","doi":"https://doi.org/10.1034/j.1600-0404.2002.1o174.x","title":"Efficacy and safety of entacapone in Parkinson's disease patients with suboptimal Levodopa response: a 6-month randomized placebo-controlled double-blind study in Germany and Austria (Celomen study)","display_name":"Efficacy and safety of entacapone in Parkinson's disease patients with suboptimal Levodopa response: a 6-month randomized placebo-controlled double-blind study in Germany and Austria (Celomen study)","alternate_titles":[],"publication_year":2002,"publication_date":"2002-04-01","ids":{"openalex":"https://openalex.org/W2119257560","doi":"https://doi.org/10.1034/j.1600-0404.2002.1o174.x","mag":"2119257560","pmid":"https://pubmed.ncbi.nlm.nih.gov/11939936"},"language":"en","primary_location":{"id":"doi:10.1034/j.1600-0404.2002.1o174.x","doi":"https://doi.org/10.1034/j.1600-0404.2002.1o174.x","is_oa":false,"landing_page_url":"https://doi.org/10.1034/j.1600-0404.2002.1o174.x","pdf_url":null,"source":{"id":"https://openalex.org/S66034498","display_name":"Acta Neurologica Scandinavica","issn_l":"0001-6314","issn":["0001-6314","1600-0404"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Neurologica Scandinavica","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2119257560"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5054677591","display_name":"Werner H Poewe","orcid":"https://orcid.org/0000-0003-4367-0971","observed_orcids":["https://orcid.org/0000-0003-4367-0971"]},"institutions":[{"id":"https://openalex.org/I143397708","display_name":"Innsbruck Medical University","ror":"https://ror.org/03pt86f80","country_code":"AT","type":"education","lineage":["https://openalex.org/I143397708"]},{"id":"https://openalex.org/I4210162546","display_name":"University Hospital Innsbruck","ror":"https://ror.org/05wjv2104","country_code":"AT","type":"healthcare","lineage":["https://openalex.org/I4210162546"]}],"countries":["AT"],"is_corresponding":true,"raw_author_name":"W. H. Poewe","raw_affiliation_strings":["Department of Neurology, University Hospital, Innsbruck, Austria. werner.poewe@uibk.ac.at","Department of Neurology, University Hospital, Innsbruck, Austria,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, University Hospital, Innsbruck, Austria. werner.poewe@uibk.ac.at","institution_ids":["https://openalex.org/I143397708","https://openalex.org/I4210162546"]},{"raw_affiliation_string":"Department of Neurology, University Hospital, Innsbruck, Austria,","institution_ids":["https://openalex.org/I143397708","https://openalex.org/I4210162546"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070448462","display_name":"G\u00fcnther Deuschl","orcid":"https://orcid.org/0000-0002-4176-9196","observed_orcids":["https://orcid.org/0000-0002-4176-9196"]},"institutions":[{"id":"https://openalex.org/I32021983","display_name":"Christian-Albrechts-Universit\u00e4t zu Kiel","ror":"https://ror.org/04v76ef78","country_code":"DE","type":"education","lineage":["https://openalex.org/I32021983"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"G. Deuschl","raw_affiliation_strings":["Department of Neurology, University of Kiel, Kiel, Germany,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, University of Kiel, Kiel, Germany,","institution_ids":["https://openalex.org/I32021983"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110300227","display_name":"A. Gordin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118237","display_name":"Orion Corporation (Finland)","ror":"https://ror.org/0296s4x19","country_code":"FI","type":"company","lineage":["https://openalex.org/I4210118237"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"A. Gordin","raw_affiliation_strings":["Research Center, Orion Pharma, Espoo, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Center, Orion Pharma, Espoo, Finland","institution_ids":["https://openalex.org/I4210118237"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052213967","display_name":"E.\u2010R. Kultalahti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118237","display_name":"Orion Corporation (Finland)","ror":"https://ror.org/0296s4x19","country_code":"FI","type":"company","lineage":["https://openalex.org/I4210118237"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"E.-R. Kultalahti","raw_affiliation_strings":["Research Center, Orion Pharma, Espoo, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Center, Orion Pharma, Espoo, Finland","institution_ids":["https://openalex.org/I4210118237"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113633132","display_name":"M. Leinonen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118237","display_name":"Orion Corporation (Finland)","ror":"https://ror.org/0296s4x19","country_code":"FI","type":"company","lineage":["https://openalex.org/I4210118237"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"M. Leinonen","raw_affiliation_strings":["Research Center, Orion Pharma, Espoo, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Center, Orion Pharma, Espoo, Finland","institution_ids":["https://openalex.org/I4210118237"]}]},{"author_position":"last","author":{"id":null,"display_name":"the Celomen Study Group","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I143397708","display_name":"Innsbruck Medical University","ror":"https://ror.org/03pt86f80","country_code":"AT","type":"education","lineage":["https://openalex.org/I143397708"]},{"id":"https://openalex.org/I4210162546","display_name":"University Hospital Innsbruck","ror":"https://ror.org/05wjv2104","country_code":"AT","type":"healthcare","lineage":["https://openalex.org/I4210162546"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"the Celomen Study Group","raw_affiliation_strings":["Department of Neurology, University Hospital, Innsbruck, Austria,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, University Hospital, Innsbruck, Austria,","institution_ids":["https://openalex.org/I143397708","https://openalex.org/I4210162546"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5054677591"],"corresponding_institution_ids":["https://openalex.org/I143397708","https://openalex.org/I4210162546"],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":null,"fwci":11.0732,"has_fulltext":false,"cited_by_count":218,"citation_normalized_percentile":{"value":0.98970213,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"105","issue":"4","first_page":"245","last_page":"255"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10919","display_name":"Deep Brain Stimulation and Movement Disorders","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10863","display_name":"Voice and Speech Disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3616","display_name":"Speech and Hearing"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/entacapone","display_name":"entacapone","score":1.0},{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.9990000128746033},{"id":"https://openalex.org/keywords/levodopa","display_name":"levodopa","score":0.859000027179718},{"id":"https://openalex.org/keywords/catechol-o-methyltransferase-inhibitors","display_name":"catechol-O-methyltransferase inhibitors","score":0.8840000033378601},{"id":"https://openalex.org/keywords/motor-fluctuations","display_name":"motor fluctuations","score":0.8920000195503235},{"id":"https://openalex.org/keywords/dyskinesia","display_name":"dyskinesia","score":0.7549999952316284},{"id":"https://openalex.org/keywords/levodopa-dose-reduction","display_name":"levodopa dose reduction","score":0.9089999794960022},{"id":"https://openalex.org/keywords/drug-withdrawal","display_name":"drug withdrawal","score":0.5490000247955322},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.4830000102519989},{"id":"https://openalex.org/keywords/drug-efficacy-and-safety","display_name":"drug safety and efficacy","score":0.492000013589859}],"concepts":[{"id":"https://openalex.org/C2776976799","wikidata":"https://www.wikidata.org/wiki/Q416444","display_name":"Entacapone","level":5,"score":0.9881374835968018},{"id":"https://openalex.org/C2780304432","wikidata":"https://www.wikidata.org/wiki/Q300989","display_name":"Levodopa","level":4,"score":0.8815289735794067},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.7050654292106628},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6973266005516052},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6647195219993591},{"id":"https://openalex.org/C2991744798","wikidata":"https://www.wikidata.org/wiki/Q608510","display_name":"Double blind","level":4,"score":0.6045749187469482},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.50278639793396},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.4462265074253082},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.26330405473709106},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2522953450679779},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.06067252159118652},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000978","descriptor_name":"Antiparkinson Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000978","descriptor_name":"Antiparkinson Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001317","descriptor_name":"Austria","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002396","descriptor_name":"Catechols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002396","descriptor_name":"Catechols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005858","descriptor_name":"Germany","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007980","descriptor_name":"Levodopa","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007980","descriptor_name":"Levodopa","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009570","descriptor_name":"Nitriles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010300","descriptor_name":"Parkinson Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010300","descriptor_name":"Parkinson Disease","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065098","descriptor_name":"Catechol O-Methyltransferase Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1034/j.1600-0404.2002.1o174.x","doi":"https://doi.org/10.1034/j.1600-0404.2002.1o174.x","is_oa":false,"landing_page_url":"https://doi.org/10.1034/j.1600-0404.2002.1o174.x","pdf_url":null,"source":{"id":"https://openalex.org/S66034498","display_name":"Acta Neurologica Scandinavica","issn_l":"0001-6314","issn":["0001-6314","1600-0404"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Neurologica Scandinavica","raw_type":"journal-article"},{"id":"pmid:11939936","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11939936","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta neurologica Scandinavica","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":26,"referenced_works":["https://openalex.org/W201588874","https://openalex.org/W1578501621","https://openalex.org/W1965770627","https://openalex.org/W1984593979","https://openalex.org/W1988136007","https://openalex.org/W1991080312","https://openalex.org/W1997845262","https://openalex.org/W2000724233","https://openalex.org/W2010206955","https://openalex.org/W2013050062","https://openalex.org/W2016759354","https://openalex.org/W2017055459","https://openalex.org/W2034770217","https://openalex.org/W2043589638","https://openalex.org/W2065015313","https://openalex.org/W2069306719","https://openalex.org/W2071948878","https://openalex.org/W2075857365","https://openalex.org/W2084669272","https://openalex.org/W2118063744","https://openalex.org/W2131721815","https://openalex.org/W2154764930","https://openalex.org/W2162840262","https://openalex.org/W2169424888","https://openalex.org/W4206634583","https://openalex.org/W4242069671"],"related_works":["https://openalex.org/W2007297814","https://openalex.org/W1984593979","https://openalex.org/W2036145467","https://openalex.org/W2170999819","https://openalex.org/W1992465464","https://openalex.org/W1970900418","https://openalex.org/W2109892234","https://openalex.org/W4385264238","https://openalex.org/W2037795767","https://openalex.org/W2401437795"],"abstract_inverted_index":{"OBJECTIVES:":[0],"To":[1],"determine":[2],"the":[3,8,37,106,109,158,220,254,264],"efficacy":[4,186,256],"and":[5,77,86,91,101,115,136,150,157,169,193,203,206,247,251,261],"safety":[6,92],"of":[7,52,67,112,257],"catechol-O-methyltransferase":[9],"(COMT)":[10],"inhibitor":[11],"entacapone,":[12],"used":[13],"as":[14],"an":[15,245],"adjunct":[16],"to":[17,263],"levodopa,":[18],"in":[19,88,235,259],"Parkinson's":[20,81],"disease":[21],"(PD)":[22],"patients.":[23],"PATIENTS":[24],"AND":[25],"METHODS:":[26],"In":[27,105,128],"this":[28],"parallel":[29],"group,":[30],"randomized,":[31],"double-blind":[32],"study,":[33],"301":[34],"PD":[35,260],"patients,":[36,130],"majority":[38],"with":[39,48,144,147,167,174],"motor":[40,116],"fluctuations,":[41],"received":[42],"entacapone":[43,68,125,145,168],"(200":[44],"mg)":[45],"or":[46,54,239],"placebo":[47,148,175,201,226],"each":[49],"daily":[50,113,159],"dose":[51,161],"standard":[53,194],"controlled-release":[55],"(CR)":[56],"levodopa.":[57],"The":[58],"24-week":[59],"treatment":[60,213],"period":[61],"was":[62,71,162,181,187,228],"followed":[63],"by":[64,73,93,124,164,171,218],"2":[65],"weeks":[66],"withdrawal.":[69,184],"Efficacy":[70],"determined":[72],"home":[74],"diaries":[75],"('on'":[76],"'off'":[78,137],"times),":[79],"Unified":[80],"Disease":[82],"Rating":[83],"Scale":[84],"(UPDRS)":[85],"changes":[87],"levodopa":[89,160,195,221,249,258],"dosage,":[90],"adverse-event":[94],"inquiry,":[95],"vital":[96,236],"signs,":[97,237],"electro":[98],"cardiography":[99],"(ECG)":[100],"laboratory":[102,240],"tests.":[103],"RESULTS:":[104],"total":[107],"population,":[108],"UPDRS":[110],"activities":[111],"living":[114],"scores":[117],"were":[118,215,232],"significantly":[119,142],"improved":[120],"(P":[121,176],"<":[122,155,177],"0.05)":[123],"vs":[126],"placebo.":[127],"fluctuating":[129],"'on'":[131],"time":[132,138],"increased":[133,170],"(1.7":[134],"h)":[135,141],"decreased":[139],"(1.5":[140],"more":[143],"than":[146],"(0.5":[149],"0.6":[151],"h,":[152],"respectively;":[153],"P":[154],"0.05),":[156],"reduced":[163],"54":[165],"mg":[166,173],"27":[172],"0.05).":[178],"Entacapone":[179,185,243],"benefit":[180],"lost":[182],"on":[183],"comparable":[188],"between":[189],"patients":[190],"using":[191],"CR":[192],"preparations.":[196],"Increased":[197],"dyskinesias":[198],"(entacapone":[199,224],"34%,":[200],"26%)":[202],"nausea":[204],"(10":[205],"5%,":[207],"respectively),":[208],"mostly":[209],"occurring":[210],"shortly":[211],"after":[212],"initiation,":[214],"generally":[216],"managed":[217],"reducing":[219],"dose.":[222],"Diarrhoea":[223],"8%,":[225],"4%)":[227],"seldom":[229],"severe.":[230],"There":[231],"no":[233],"differences":[234],"ECG":[238],"results.":[241],"CONCLUSION:":[242],"is":[244],"effective":[246],"safe":[248],"extender":[250],"enhancer,":[252],"improving":[253],"symptomatic":[255],"adding":[262],"patients'":[265],"benefit.":[266]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2119257560","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":11},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":9},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
